Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Multi Center, Randomized, Double-blind, Positive Controlled Phase II Clinical Trial of Bicyclol Tablets in the Treatment of Acute Drug-induced Liver Injury

NCT02944552 is registered in ClinicalTrials.gov with Drug Induced Liver Disease Study Group as lead sponsor.

NCT NCT02944552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02944552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Multi Center, Randomized, Double-blind, Positive Controlled Phase II Clinical Trial of Bicyclol Tablets in the Treatment of Acute Drug-induced Liver Injury
Lead sponsor
Drug Induced Liver Disease Study Group
Phase
Phase 2
Overall status
Completed
Start date
August 18, 2017
Completion date
July 31, 2019
Enrollment
244 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced acute liver injury